Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 2 Apr 20 EFFECT Notice of effectiveness
- 1 Apr 20 424B3 Prospectus supplement
- 30 Mar 20 S-4/A Registration of securities issued in business combination transactions (amended)
-
13 Mar 20 S-4/A Registration of securities issued in business combination transactions (amended)
- 7 Feb 20 S-4 Registration of securities issued in business combination transactions
HSTO similar filings
Filing view
External links
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated March 11, 2020, in Amendment No. 1 to the Registration Statement (Form S-4 No. 333-236332) and related Prospectus of Conatus Pharmaceuticals Inc. for the registration of shares of its common stock.
/s/ Ernst & Young LLP
San Diego, California
March 13, 2020